TGF-β has been shown to enhance YAP expression, and YAP silencing or inhibition with cerivastatin, verteporfin, TED-347, and CA3 has been shown to significantly reduce myofibroblast differentiation and collagen formation in TGF-β-induced TAO (123). This evidence concerns the gene TGFB1 and thromboangiitis obliterans.